Literature DB >> 27062150

Establishment of a ternary network system for evaluating the antioxidant fraction of Danhong injection.

Yan Wang1,2, Zhenzuo Jiang1,2, Fan Yang1,2, Xin Chai1,2, Yan Zhu1,2, Xiaoya Zhao1,2, Miaomiao Jiang1,2, Jing Yang1,2, Buchang Zhao3, Ke Qian3, Yuefei Wang1,2.   

Abstract

Oxidative stress plays a crucial role in numerous cardiovascular diseases. As an effective therapy, Danhong injection (DHI) is considered to act through an antioxidant mechanism for the treatment of cardiovascular disease. In our study, we focused on the potential contribution of the antioxidant capacity of DHI fractions (Frs) and established an innovative screening method based on a 2,2-diphenyl-1-picrylhydrazyl radical scavenging activity assay. A ternary network evaluation system, which was constructed based on the radical scavenging activity, the area under the activity-concentration curve and the solid content of the fractions, was implemented to select the fractions that posed the greatest antioxidant effect. As a result, Frs 5-7 and Frs 17-19 were shown to exhibit superior antioxidant activity according to the regression area of the ternary network, which was >0.5. Furthermore, the active fractions were characterized by ultra-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry combined with nuclear magnetic resonance. This study provided an effective method for the comprehensive evaluation of the antioxidant effect of DHI fractions.
Copyright © 2016 John Wiley & Sons, Ltd. Copyright © 2016 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Danhong injection; NMR; UPLC-Q/TOF MS; antioxidant activity; ternary network evaluation system

Mesh:

Substances:

Year:  2016        PMID: 27062150     DOI: 10.1002/bmc.3739

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  4 in total

1.  Network pharmacology exploration reveals endothelial inflammation as a common mechanism for stroke and coronary artery disease treatment of Danhong injection.

Authors:  Ming Lyu; Chun-Lin Yan; Hai-Xin Liu; Tai-Yi Wang; Xin-Hui Shi; Jin-Ping Liu; John Orgah; Guan-Wei Fan; Ji-Hong Han; Xiao-Ying Wang; Yan Zhu
Journal:  Sci Rep       Date:  2017-11-13       Impact factor: 4.379

2.  Specific Combination of Salvianolic Acids As Core Active Ingredients of Danhong Injection for Treatment of Arterial Thrombosis and Its Derived Dry Gangrene.

Authors:  Tiechan Zhao; Lianying Chang; Boyong Zhang; Ming Lu; Xiaoyi Wang; John O Orgah; Yuefei Wang; Xiaoxuan Tian; Jing Yang; Guanwei Fan; Boli Zhang; Yan Zhu
Journal:  Front Pharmacol       Date:  2017-06-13       Impact factor: 5.810

3.  A Comprehensive Strategy to Evaluate Compatible Stability of Chinese Medicine Injection and Infusion Solutions Based on Chemical Analysis and Bioactivity Assay.

Authors:  Jian-Ping Li; Yang Liu; Jian-Ming Guo; Er-Xin Shang; Zhen-Hua Zhu; Kevin Y Zhu; Yu-Ping Tang; Bu-Chang Zhao; Zhi-Shu Tang; Jin-Ao Duan
Journal:  Front Pharmacol       Date:  2017-11-15       Impact factor: 5.810

4.  Danhong Injection Protects Hemorrhagic Brain by Increasing Peroxiredoxin 1 in Aged Rats.

Authors:  Shang Wang; Lie Yu; Guifang Sun; Yu Liu; Wentao Hu; Yanru Liu; Tao Peng; Xiaojun Wang; Jingliang Cheng; Aravintakumar Sr; Bo Qin; Hong Lu
Journal:  Front Pharmacol       Date:  2020-03-25       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.